We do believe the issues cited were very minor, and I think the fine is probably an indication of the view of severity.
This investment will allow us to meet our clients' growing demand for high-science, first-in-human clinical trial services and address one of their toughest drug development challenges.
Copyright © 2024 Electric Goat Media. All Rights Reserved.